Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19.

ABSTRACT:

Background

New-onset atrial fibrillation (AF) during COVID-19 infection is associated with worse cardiovascular outcomes and mortality, with new-onset AF being associated with worse clinical outcomes than recurrent AF. However, it is not known whether a prior history of AF is an independent cardiovascular risk factor predicting worse outcomes in COVID-19 patients. The present investigation sought to determine whether AF should be considered a risk factor for worse outcomes in COVID-19 illness.

Methods

From March 2020-September 2021 patients testing positive for SARS-CoV-2 with a prior AF diagnosis (n = 3623) were propensity matched to non-AF SARS-CoV-2 positive patients (n = 3610). Multivariable Cox hazard regression was used to determine subsequent MACE (all-cause death, my

SUBMITTER: Cutler MJ 

PROVIDER: S-EPMC9513337 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature